全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Reconstruction of Mandibular Defects Using Bone Morphogenic Protein: Can Growth Factors Replace the Need for Autologous Bone Grafts? A Systematic Review of the Literature

DOI: 10.1155/2011/165824

Full-Text   Cite this paper   Add to My Lib

Abstract:

Autogenous bone is still considered the “gold standard” of regenerative and reconstructive procedures involving mandibular defects. However, harvesting of this material can lead to many complications like increasing morbidity, expanding of the surgical time, and incomplete healing of the donor site. In the last few years many authors looked for the development of effective reconstruction procedures using osteoinductive factors without the need for conventional bone grafting. The first-in-human study involving the use of Bone Morphongenic Proteins (rhBMP) for mandibular reconstruction was performed in 2001 by Moghadam. Only few articles have been reported in the literature since then. The purpose of this study was to search and analyze the literature involving the use of rhBMP for reconstruction of mandibular defects. In all the studies reported, authors agree that the use of grown factors may represent the future of regenerative procedures with more research necessary for confirmation. 1. Introduction Tissue engineering holds great promise for revolutionizing many grafting procedures. Continuity defects of the mandible frequently result from tumor removal or significant trauma, and reconstruction of these defects can be challenging. For defects with extensive hard and soft tissue loss, microvascular free tissue transfer often provides an excellent reconstructive option. However, significant site morbidity as well as non ideal bone stock for dental implant rehabilitation may occur [1]. The development of bone morphogenic proteins (BMPs) has offered an alternative to traditional bone grafting, which has been the gold standard for oral and maxillofacial reconstruction [2]. Clinical application of BMPs has evolved to include defects of the facial skeleton including those involving the mandible and maxilla [3]. There have been many reports of the use of BMPs regarding orthopaedic as well as alveolar augmentation. There have been few studies addressing the use of BMP in reconstructing critical-size defects of the mandible. The purpose of this study is to evaluate the different study present in the literature concerning the use of growth factors for the reconstruction of mandibular defects, comparing the method and the finals results. A well-identified guideline is in fact not still available and, because of that, significative differences could be find analysing the literature on that topic. 2. Background Failure to adequately restore mandibular continuity defects often result in poor function for the patient postsurgically. Various bone grafting and bone

References

[1]  A. S. Herford, “rhBMP-2 as an option for reconstructing mandibular continuity defects,” Journal of Oral and Maxillofacial Surgery, vol. 67, no. 12, pp. 2679–2684, 2009.
[2]  M. R. Urist, “Bone: formation by autoinduction,” Science, vol. 150, no. 3698, pp. 893–899, 1965.
[3]  A. S. Herford, P. J. Boyne, and R. P. Williams, “Clinical applications of rhBMP-2 in maxillofacial surgery,” Journal of the California Dental Association, vol. 35, no. 5, pp. 335–341, 2007.
[4]  A. S. Herford and P. J. Boyne, “Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2),” Journal of Oral and Maxillofacial Surgery, vol. 66, no. 4, pp. 616–624, 2008.
[5]  J. M. Lane, A. W. Yasko, E. Tomin et al., “Bone marrow and recombinant human bone morphogenetic protein-2 in osseous repair,” Clinical Orthopaedics and Related Research, no. 361, pp. 216–227, 1999.
[6]  R. E. Marx and M. J. Morales, “Morbidity from bone harvest in major jaw reconstruction: a randomized trial comparing the lateral anterior and posterior approaches to the ilium,” Journal of Oral and Maxillofacial Surgery, vol. 46, no. 3, pp. 196–203, 1988.
[7]  P. J. Boyne, “Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects,” Journal of Bone and Joint Surgery—Series A, vol. 83, no. 2, pp. 146–150, 2001.
[8]  P. J. Boyne, S. Salina, A. Nakamura, F. Audia, and S. Shabahang, “Bone regeneration using rhBMP-2 induction in hemimandibulectomy type defects of elderly sub-human primates,” Cell and Tissue Banking, vol. 7, no. 1, pp. 1–10, 2006.
[9]  P. J. Boyne, L. C. Lilly, R. E. Marx et al., “De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation,” Journal of Oral and Maxillofacial Surgery, vol. 63, no. 12, pp. 1693–1707, 2005.
[10]  W. M. M. T. van Hout, A. B. M. van der Molen, C. C. Breugem, R. Koole, and E. M. van Cann, “Reconstruction of the alveolar cleft: can growth factor-aided tissue engineering replace autologous bone grafting? A literature review and systematic review of results obtained with bone morphogenetic protein-2,” Clinical Oral Investigations, vol. 15, no. 3, pp. 297–303, 2011.
[11]  G. K. B. Sàndor, B. N. Rittenberg, C. M. L. Clokie, and M. F. Caminiti, “Clinical success in harvesting autogenous bone using a minimally invasive trephine,” Journal of Oral and Maxillofacial Surgery, vol. 61, no. 2, pp. 164–168, 2003.
[12]  H. Burchardt, “The biology of bone graft repair,” Clinical Orthopaedics and Related Research, vol. 174, pp. 28–42, 1983.
[13]  J. M. Wozney, V. Rosen, A. J. Celeste et al., “Novel regulators of bone formation: molecular clones and activities,” Science, vol. 242, no. 4885, pp. 1528–1534, 1988.
[14]  J. M. Wozney, “The bone morphogenetic protein family and osteogenesis,” Molecular Reproduction and Development, vol. 32, no. 2, pp. 160–167, 1992.
[15]  A. S. Herford and M. Cicciù, “Recombinant human bone morphogenetic protein type 2 jaw reconstruction in patients affected by giant cell tumor,” Journal of Craniofacial Surgery, vol. 21, no. 6, pp. 1970–1975, 2010.
[16]  H. G. Moghadam, M. R. Urist, G. K. B. Sandor, and C. M. L. Clokie, “Successful mandibular reconstruction using a BMP bioimplant,” Journal of Craniofacial Surgery, vol. 12, no. 2, pp. 119–127, 2001.
[17]  C. M. L. Clokie and G. K. B. Sándor, “Reconstruction of 10 major mandibular defects using bioimplants containing BMP-7,” Journal of the Canadian Dental Association, vol. 74, no. 1, pp. 67–72, 2008.
[18]  T. G. Carter, P. S. Brar, A. Tolas, and O. R. Beirne, “Off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) for reconstruction of mandibular bone defects in humans,” Journal of Oral and Maxillofacial Surgery, vol. 66, no. 7, pp. 1417–1425, 2008.
[19]  A. N. Glied and R. A. Kraut, “Off-label use of rhBMP-2 for reconstruction of critical-sized mandibular defects,” New York State Dental Journal, vol. 76, no. 4, pp. 32–35, 2010.
[20]  P. Warnke, I. Springer, P. J. Wiltfang et al., “Growth and transplantation of a custom vascularised bone graft in a man,” The Lancet, vol. 364, no. 9436, pp. 766–770, 2004.
[21]  P. H. Warnke, J. Wiltfang, I. Springer et al., “Man as living bioreactor: fate of an exogenously prepared customized tissue-engineered mandible,” Biomaterials, vol. 27, no. 17, pp. 3163–3167, 2006.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133